Drug Profile
PEG-peptoid - Xfibra
Alternative Names: PEG-30kDa-peptoid; Polyethylene glycol-peptoidLatest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator Xfibra
- Class Peptoids; Polyethylene glycols
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Liver cirrhosis
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Liver cirrhosis in USA (Parenteral)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Liver-Cirrhosis in USA (Parenteral)
- 19 Jul 2016 Preclinical trials in Cirrhosis in USA (Parenteral)